ARSL and lung cancer: MUC5B, HAPBP2, SPDEF, ICA1, FZD7, CHST7, SLC2A9, ACOX2, KCNK5, ARSE, P2RY1, CSTA, ALDOC, and ANXA8 seem to retain the capability of separating the two lung cancer types.